Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving Breast Cancer Outcomes by Enhanced Activities in Early Detection and Diagnosis: An Umbrella Review and Meta-Analyses of Randomised Controlled Trials in High-Income Contexts With Universal Healthcare Coverage.

Cancer control : journal of the Moffitt Cancer Center·2026
Same author

DNA methylation-mediated memory of obesity in CD4 T lymphocytes perpetuates immune dysregulation.

EMBO reports·2026
Same author

Multimodal AI-driven analysis in breast and lung cancer: insights from the OPTIMA prototyping workshop.

BMC proceedings·2026
Same author

Toward cervical cancer prevention and elimination in the Eastern Mediterranean Region: Current landscape and opportunities for evidence-based action.

Preventive medicine·2026
Same author

Evaluation of the Quality and Suitability of Self-Collected Vaginal and Urine Samples for Human Papillomavirus Testing: A Prospective Matched Study.

BJOG : an international journal of obstetrics and gynaecology·2026
Same author

The Use of First-Void Urine to Screen Women Aged 60-79 for HPV in the UK: The Catch-Up Screen Study.

BJOG : an international journal of obstetrics and gynaecology·2025

Related Experiment Video

Updated: May 8, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K

Epigenetic Biomarkers for Cervical Cancer Progression: A Scoping Review.

Efthymios Ladoukakis1, Gracia Andriamiadana2, Fatema Hajizadah3

  • 1Molecular Epidemiology Laboratory, Wolfson Institute of Population Health, Queen Mary University of London, London EC1M 6BQ, UK.

International Journal of Molecular Sciences
|October 16, 2025
PubMed
Summary

This review explores epigenetic biomarkers beyond DNA methylation for cervical cancer. It highlights histone modifications, non-coding RNAs, and repetitive elements as promising avenues for improved detection and management.

Keywords:
biomarkerscervical cancercircRNAepigenomicshistone modificationslncRNAmiRNAmtDNApiRNArepetitive elementstransposable elements

More Related Videos

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

9.0K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.1K

Related Experiment Videos

Last Updated: May 8, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

9.0K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.1K

Area of Science:

  • Epigenetics
  • Oncology
  • Molecular Biology

Background:

  • Cervical cancer is a significant global health issue, particularly in low-resource settings.
  • Existing HPV vaccines have not eradicated the disease, necessitating novel detection and treatment strategies.
  • Traditional focus on nuclear DNA methylation as a biomarker overlooks other epigenetic mechanisms.

Purpose of the Study:

  • To conduct a scoping review of underexplored epigenetic biomarkers for cervical cancer.
  • To shift focus beyond global nuclear DNA methylation to other epigenetic modifications.
  • To identify potential biomarkers for early detection and personalized management.

Main Methods:

  • Literature search using Google Scholar and Publish or Perish software.
  • Inclusion of studies published up to January 2025.
  • Focus on mitochondrial DNA, non-coding RNA, histone modifications, and repetitive elements.

Main Results:

  • Mitochondrial DNA methylation shows limited evidence as a biomarker.
  • Histone modifications are consistently linked to cervical cancer development and progression.
  • Aberrant expression of lncRNAs, circRNAs, miRNAs, and piRNAs correlates with poor prognosis.
  • Hypomethylation of repetitive elements (LINE-1, Alu) contributes to genomic instability and tumorigenesis.

Conclusions:

  • Alternative epigenetic mechanisms offer promising biomarker potential for cervical cancer.
  • Expanding biomarker discovery beyond nuclear DNA methylation is crucial.
  • Understanding these epigenetic alterations can enhance early detection and personalized treatment strategies.